BVF

BVF as of Dec. 31, 2012

Portfolio Holdings for BVF

BVF holds 36 positions in its portfolio as reported in the December 2012 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Ligand Pharmaceuticals In (LGND) 13.7 $74M 3.6M 20.74
Ironwood Pharmaceuticals (IRWD) 10.8 $59M 5.3M 11.09
Chemocentryx 10.1 $55M 5.0M 10.94
Rigel Pharmaceuticals 9.4 $51M 7.9M 6.50
Array BioPharma 7.8 $43M 11M 3.72
Qlt 6.3 $34M 4.4M 7.86
Amgen (AMGN) 5.4 $29M 341k 86.20
Targacept 5.0 $27M 6.2M 4.38
Ym Biosciences 4.1 $22M 7.8M 2.87
Nektar Therapeutics 3.7 $20M 2.7M 7.41
Regulus Therapeutics 3.2 $17M 2.7M 6.30
Endocyte 2.7 $15M 1.6M 8.98
Exelixis Inc cnv 2.1 $12M 12M 0.96
ISIS Pharmaceuticals 1.9 $11M 1.0M 10.46
Exelixis (EXEL) 1.9 $10M 2.2M 4.57
Pain Therapeutics 1.6 $8.8M 3.3M 2.71
ACADIA Pharmaceuticals (ACAD) 1.6 $8.4M 1.8M 4.65
A.P. Pharma (APPA) 1.3 $7.2M 13M 0.54
Cytokinetics 1.3 $6.8M 10M 0.66
Myrexis (MYRX) 0.9 $4.7M 1.7M 2.83
Oncothyreon 0.8 $4.3M 2.3M 1.92
Vanda Pharmaceuticals (VNDA) 0.8 $4.2M 1.1M 3.70
ArQule 0.6 $3.4M 1.2M 2.79
Palatin Technologies 0.6 $3.1M 5.2M 0.60
Sangamo Biosciences (SGMO) 0.4 $2.2M 371k 6.01
AVANIR Pharmaceuticals 0.4 $2.1M 782k 2.63
DURECT Corporation 0.3 $1.9M 2.1M 0.92
Genvec 0.3 $1.5M 1.1M 1.34
Capstone Therapeutics 0.2 $1.3M 7.8M 0.17
Anthera Pharmaceuticals 0.2 $916k 1.5M 0.62
Flamel Technologies 0.1 $656k 217k 3.03
Transcept Pharmaceuticals 0.1 $668k 150k 4.45
Astex Pharmaceuticals 0.1 $540k 186k 2.91
Cadus Corporation 0.1 $377k 269k 1.40
NeurogesX 0.1 $275k 1.2M 0.23
AutoImmune (AIMM) 0.0 $0 3.6M 0.00